Pro­duc­tion halt­ed at Ko­re­an phar­ma af­ter reg­u­la­tors find unau­tho­rized ad­di­tives in 13 drugs

Months af­ter the South Ko­re­an phar­ma Vivo­zon was or­dered to re­call and dis­card 13 drugs af­ter vi­o­lat­ing good man­u­fac­tur­ing prac­tice stan­dards, the Min­istry of Food and Drug Safe­ty has or­dered sus­pen­sions for a num­ber of drugs in­volved.

Any drugs that were found to have unau­tho­rized ad­di­tives have been sus­pend­ed for four months, the Ko­rea Bio­med­ical Re­view re­port­ed Fri­day. Tablet pro­duc­tion is sus­pend­ed for a month and 29 days, while cap­sule pro­duc­tion was sus­pend­ed for six weeks, and syrup pro­duc­tion for five.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER